STA Pharmaceutical and Regulus Therapeutics have entered into a collaboration agreement covering oligonucleotide synthesis for research and mid-scale non-GMP/cGMP manufacturing. STA becomes a strategic development and manufacturing partner for Regulus’s preclinical and clinical programmes of microRNA-targeting drugs. Regulus will provide…